IDEXX Laboratories (BSP:I1DX34) Additional Paid-In Capital : R$7,991 Mil(As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is IDEXX Laboratories Additional Paid-In Capital?

IDEXX Laboratories's quarterly additional paid-in capital increased from Sep. 2023 (R$7,621 Mil) to Dec. 2023 (R$7,691 Mil) and increased from Dec. 2023 (R$7,691 Mil) to Mar. 2024 (R$7,991 Mil).

IDEXX Laboratories's annual additional paid-in capital declined from Dec. 2021 (R$7,789 Mil) to Dec. 2022 (R$7,675 Mil) but then increased from Dec. 2022 (R$7,675 Mil) to Dec. 2023 (R$7,691 Mil).

IDEXX Laboratories Additional Paid-In Capital Historical Data

The historical data trend for IDEXX Laboratories's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Additional Paid-In Capital Chart

IDEXX Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

4,980.88

6,661.61

7,788.61

7,675.15

7,690.56

IDEXX Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															7,760.31	7,354.31	7,620.53	7,690.56	7,991.33

IDEXX Laboratories Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

IDEXX Laboratories Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

IDEXX Laboratories (BSP:I1DX34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (BSP:I1DX34) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

IDXX:USA IDXX:Mexico IX1:Germany IDXX:Austria

Address

One IDEXX Drive, Westbrook, ME, USA, 04092

Website

https://www.idexx.com

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.

IDEXX Laboratories (BSP:I1DX34) Headlines

No Headlines